Titre:
  • Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952.
Auteur:Bouwhuis, Marna G; Suciu, Stefan; Kruit, Wim H; Sales, François; Stoitchkov, K; Patel, P I; Cocquyt, Veronique; Thomas, J.; Lienard, Danielle; Eggermont, A; Ghanem, Ghanem Elias; European Organisation for Research and Treatment of Cancer Melanoma Group,
Informations sur la publication:European journal of cancer, 47, 3, page (361-368)
Statut de publication:Publié, 2011-02
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Antineoplastic Agents -- therapeutic use
Female
Humans
Interferon-alpha -- therapeutic use
Kaplan-Meier Estimate
Male
Melanoma -- blood -- mortality
Middle Aged
Neoplasm Metastasis
Prognosis
Recombinant Proteins
S100 Proteins -- blood
Skin Neoplasms -- blood -- mortality
Tumor Markers, Biological -- blood
Young Adult
Note générale:Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2010.10.005
info:pii/S0959-8049(10)00990-1
info:scp/79251599240
info:pmid/21087856